National Bone Health Alliance
Strong Bones America

Mechanistic and Therapeutic Insights into Skeletal Biology Learned from the Study of Rare Bone Diseases


Thursday, September 11th, 2014 (One day prior to the ASBMR 2014 Annual Meeting)

George R. Brown Convention Center, 1001 Avenida De Las Americas, Houston, TX 

Workshop Summary:  To date, nearly 500 unique rare bone diseases have been described, which in the aggregate affect 1 in 5,000 live births, and comprise 5% of all birth defects. Typically the disability caused by these diseases affects individuals throughout their lives. Currently, the vast majority of these disorders have no cure, yet studying rare bone diseases has helped elucidate biological pathways and reveal valuable targets for drug discovery that are benefitting patients with common bone diseases too.

This workshop, coordinated by the National Bone Health Alliance (NBHA) in partnership with the Rare Bone Disease Patient Network and with the support of the American Society for Bone and Mineral Research (ASBMR) and the United States Bone and Joint Initiative (USBJI) aims to:

1)     Convene a multi-disciplinary group of experts including researchers, clinicians, and patients with rare bone diseases to advance our understanding of skeletal biology and encourage the development of novel therapies to improve outcomes for individuals with both common and rare bone diseases;

2)     Identify gaps in our knowledge regarding the biologic mechanisms underlying rare bone disorders and share effective research strategies in translational and therapeutic areas;

3)     Encourage broad participation both by holding the event the day before the ASBMR 2014 Annual Meeting and providing funding for a significant number of young investigators to attend; and

4)     Disseminate the results broadly by publishing the proceedings of the program in a peer-reviewed journal.

The one-day workshop will include lectures by invited speakers, and multiple opportunities to initiate collaborations and encourage future research partnerships.

Click here to view the preliminary agenda.

Click here to view the members of the NBHA Rare Bone Disease Working Group and Rare Bone Disease Patient Network.

Register for this workshop via the ASBMR Annual Meeting website:

This workshop is supported in part by unrestricted educational grants from the following companies:




Fearing Drugs’ Rare Side Effects, Millions Take Their Chances With Osteoporosis

Millions of Americans are missing out on a chance to avoid debilitating fractures from weakened bones, researchers say, because they are terrified of exceedingly rare side effects from drugs that can help them.  Last month, the American Society for Bone and Mineral Research, the National Ost

Member spotlight

Lymphangiomatosis & Gorham's Disease Alliance

The Lymphangiomatosis & Gorham's Disease Alliance is a patient support foundation focused on providing disease information, helping to find access to medical expertise, and supporting research for two poorly understood, very rare diseases of unknown etiology: lymphangiomatosis and Gorham's disease. These two diseases, which can affect bones, soft tissue and viscera, are benign, but dangerous in infants and young children - especially with infiltration of lesions involving the spine or thoracic region.